Immunic AG | WebDisclosure

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
Immunic AG

PRESS RELEASE

published on 09/25/2025 at 12:30, 4 months 12 days ago

Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis
Immunic presented key Vidofludimus Calcium data at the 41st Congress of ECTRIMS, highlighting its potential in multiple sclerosis. The data underscore its neuroprotective potential and promise to slow disease progression

Multiple Sclerosis Immunic Vidofludimus Calcium ECTRIMS Congress Neuroprotective Potential
BRIEF

published on 09/09/2025 at 12:35, 4 months 28 days ago

Immunic obtient un brevet américain pour le vidofludimus calcique dans le traitement de la sclérose en plaques

Sclérose En Plaques Essai De Phase 2 Immunique Vidofludimus Calcique Allocation De Brevet
BRIEF

published on 09/09/2025 at 12:35, 4 months 28 days ago

Immunic Secures U.S. Patent for Vidofludimus Calcium in Multiple Sclerosis

Multiple Sclerosis Immunic Vidofludimus Calcium Phase 2 Trial Patent Allowance
PRESS RELEASE

published on 09/09/2025 at 12:30, 4 months 28 days ago

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis
Immunic receives United States Patent Notice of Allowance for Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis, extending protection into 2041

United States Patent Immunic Vidofludimus Calcium Progressive Multiple Sclerosis Patent Notice Of Allowance
BRIEF

published on 09/04/2025 at 12:35, 5 months 3 days ago

Immunic Announces Participation in Key Conferences

Immunic Vidofludimus Calcium Investor Meetings Biopharma Conference ECTRIMS 2025
BRIEF

published on 09/04/2025 at 12:35, 5 months 3 days ago

Immunic annonce sa participation à des conférences clés

Réunions D'investisseurs Immunique Vidofludimus Calcique ECTRIMS 2025 Conférence Biopharmaceutique
PRESS RELEASE

published on 09/04/2025 at 12:30, 5 months 3 days ago

Immunic to Participate in Investor and Scientific Conferences in September
Immunic, Inc. (Nasdaq: IMUX) to participate in investor and scientific conferences in September, including H.C. Wainwright 27th Annual Global Investment Conference and ECTRIMS Congress

Investor Conference Clinical Pipeline Scientific Conference Immunic Inc ECTRIMS Congress
BRIEF

published on 08/07/2025 at 12:35, 6 months ago

Immunic Reports Q2 2025 Financial Results with Vidofludimus Calcium Progress

Vidofludimus Calcium Multiple Sclerosis Trials R&D Expenses Biotech Investment Immunic Financial Results
BRIEF

published on 08/07/2025 at 12:35, 6 months ago

Immunic publie ses résultats financiers du deuxième trimestre 2025 avec les progrès du Vidofludimus Calcium

Essais Sur La Sclérose En Plaques Dépenses De R&D Vidofludimus Calcique Résultats Financiers D'Immunic Investissement Dans Les Biotechnologies
PRESS RELEASE

published on 08/07/2025 at 12:30, 6 months ago

Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports positive Q2 2025 results with focus on clinical progress of vidofludimus calcium for multiple sclerosis treatment

Clinical Trials Immunic Inc. Multiple Sclerosis Vidofludimus Calcium Q2 2025 Results

Accesswire

Published on 02/07/2026 at 01:00, 1 day 3 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 5 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 6 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 12 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 14 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 7 hours 15 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 11 hours 40 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 11 hours 55 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 8 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 10 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 9 hours ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 1 day 9 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 12 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 1 day 12 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 1 day 20 hours ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE